Evidence map›Paper›PMID 32321849›Full record

ArticleTobacco control2020

Longitudinal pathways of exclusive and polytobacco hookah use among youth, young adults and adults in the USA: findings from the PATH Study Waves 1-3 (2013-2016).

Eva Sharma, Maansi Bansal-Travers, Kathryn C Edwards, Michael J Halenar, Kristie A Taylor, Karin A Kasza, Hannah Day, Hoda T Hammad, Gabriella Anic, Jean Limpert and 6 more

Abstract read
In one paragraph

Article in Tobacco control, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Interventions for waterpipe smoking cessation.The Cochrane database of systematic reviews · 2023
    Pooled it
  2. Trial
  3. Trial
  4. Testing the Effects of Hookah Tobacco Social Media Risk Communication Messages Among Young Adults.Health education & behavior : the official publication of the Society for Public Health Education · 2021
    Trial
  5. Trial
  6. Article
  7. Article
  8. Unsubstantiated Claims by the Hookah Tobacco Industry to Exempt Flavored Hookah Tobacco Products From Flavor Bans.Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco · 2025
    Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Marijuana, e-cigarette, and tobacco product use in young adults who underwent pediatric bariatric surgery.Surgery for obesity and related diseases : official journal of the American Society for Bariatric Surgery · 2023
    Observational
  16. Article
  17. Article
  18. Article
  19. Article
  20. Tobacco and Nicotine Use Among US Adult "Never Smokers" in Wave 4 (2016-2018) of the Population Assessment of Tobacco and Health Study.Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Eva SharmaBehavioral Health and Health Policy Practice, Westat, Rockville, MD, United States EvaSharma@westat.com.ORCID 0000-0002-1328-508X
Maansi Bansal-TraversDepartment of Health Behavior, Roswell Park Comprehensive Cancer Center, Buffalo, NY, United States.ORCID 0000-0002-7944-3570
Kathryn C EdwardsBehavioral Health and Health Policy Practice, Westat, Rockville, MD, United States.ORCID 0000-0002-0645-1705
Michael J HalenarBehavioral Health and Health Policy Practice, Westat, Rockville, MD, United States.ORCID 0000-0002-8703-3811
Kristie A TaylorBehavioral Health and Health Policy Practice, Westat, Rockville, MD, United States.ORCID 0000-0001-6668-7923
Karin A KaszaDepartment of Health Behavior, Roswell Park Comprehensive Cancer Center, Buffalo, NY, United States.ORCID 0000-0002-4492-098X
Hannah DayOffice of Science, Center for Tobacco Products, Food and Drug Administration, Silver Spring, MD, United States.
Hoda T HammadOffice of Science, Center for Tobacco Products, Food and Drug Administration, Silver Spring, MD, United States.
Gabriella AnicOffice of Science, Center for Tobacco Products, Food and Drug Administration, Silver Spring, MD, United States.
Jean LimpertOffice of Science, Center for Tobacco Products, Food and Drug Administration, Silver Spring, MD, United States.
Lisa D GardnerOffice of Science, Center for Tobacco Products, Food and Drug Administration, Silver Spring, MD, United States.ORCID 0000-0003-3340-2818
Nicolette BorekOffice of Science, Center for Tobacco Products, Food and Drug Administration, Silver Spring, MD, United States.
Heather L KimmelNational Institute on Drug Abuse, National Institutes of Health, Bethesda, MD, United States.ORCID 0000-0001-8278-0095
Wilson M ComptonNational Institute on Drug Abuse, National Institutes of Health, Bethesda, MD, United States.
Andrew HylandDepartment of Health Behavior, Roswell Park Comprehensive Cancer Center, Buffalo, NY, United States.
Cassandra A StantonBehavioral Health and Health Policy Practice, Westat, Rockville, MD, United States.ORCID 0000-0001-5329-6261

Funding

NIDA NIH HHS HHSN271201100027C
6 · The paper itself

Abstract

objectiveThe goal of this study is to examine cross-sectional rates of use and longitudinal pathways of hookah use among US youth (ages 12-17), young adults (ages 18-24), and adults 25+ (ages 25 and older).

designData were drawn from the first three waves (2013-2016) of the Population Assessment of Tobacco and Health Study, a nationally representative, longitudinal cohort study of US adults and youth. Respondents with data at all three waves (youth, n=11 046; young adults, n=6478; adults 25+, n=17 188) were included in longitudinal analyses.

resultsYoung adults had higher ever, past 12-month (P12M) and past 30-day cross-sectional prevalence of hookah use at each wave than youth or adults 25+. The majority of Wave 1 (W1) hookah users were P12M users of other tobacco products (youth: 73.9%, young adults: 80.5%, adults 25+: 83.2%). Most youth and adult W1 P12M hookah users discontinued use in Wave 2 or Wave 3 (youth: 58.0%, young adults: 47.5%, adults 25+: 63.4%). Most W1 P12M hookah polytobacco users used cigarettes (youth: 49.4%, young adults: 59.4%, adults 25+: 63.2%) and had lower rates of quitting all tobacco than exclusive hookah users or hookah polytobacco users who did not use cigarettes.

conclusionsHookah use is more common among young adults than among youth or adults 25+. Discontinuing hookah use is the most common pathway among exclusive or polytobacco hookah users. Understanding longitudinal transitions in hookah use is important in understanding behavioural outcomes at the population level.

Indexed as

Smoking Water PipesAdolescentAdultAge FactorsChildCross-Sectional StudiesHumansLongitudinal StudiesSmoking CessationTime FactorsTobacco ProductsTobacco UseTobacco, WaterpipeUnited StatesWater Pipe SmokingYoung Adultnon-cigarette tobacco productspreventionsurveillance and monitoring

Identifiers

PMID32321849
PMCPMC7523186

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.